000 01400nam a2200337Ia 4500
001 CRC00E53485PDF
003 BD-DhSAU
005 20151012144300.0
006 m|||||o||d||||||||
007 cr||||
008 080728s2009 flu sb 001 0 eng d
020 _a9781420053494 (ebook : PDF)
040 _aBD-DhSAU
_cBD-DhSAU
090 _aRS199.M53
_bC57 2009
092 _a615.19
_bC644
100 1 _aClontz, Lucia.
245 1 0 _aMicrobial limit and bioburden tests
_h[electronic resource] :
_bvalidation approaches and global requirements /
_cLucia Clontz.
250 _a2nd ed.
260 _aBoca Raton :
_bTaylor & Francis,
_c2009.
300 _a280 p.
500 _aRev. ed. of: Microbial limit and bioburden tests for the pharmaceutical industry.
504 _aIncludes bibliographical references and index.
530 _aAlso available in print edition.
_bCRC Press (http://www.crcpress.com)
538 _aMode of access: World Wide Web.
650 0 _aDrugs
_xMicrobiology
_xStandards.
650 0 _aMicrobial contamination
_xMeasurement
_xStandards.
655 7 _aElectronic books.
_2lcsh
700 1 _aClontz, Lucia.
_tMicrobial limit and bioburden tests for the pharmaceutical industry.
776 1 _z9781420053487
856 4 0 _uhttp://marc.crcnetbase.com/isbn/9781420053494
_qapplication/PDF
999 _c11204
_d11203